- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GENPHARMASEC's board has approved its 34th Annual General Meeting (AGM) for September 29, 2026, to be held virtually. Key dates for e-voting (September 26-28, 2026) and book closure (September 23-29, 2026) were also set. The board approved the Annual Report and Director's Report for the financial year 2025-26. Shareholders will vote on the re-appointment of Mr. Sohan Chaturvedi as Whole Time Director and a proposal to advance loans or give guarantees, subject to shareholder approval. These approvals ensure ongoing corporate governance and strategic financial flexibility for the company.